Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Italian Stock Exchange  >  DiaSorin S.p.A.    DIA   IT0003492391

DIASORIN S.P.A.

(DIA)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Italian Stock Exchange
11/23/2020 11/24/2020 11/25/2020 11/26/2020 11/27/2020 Date
173.5(c) 165.1(c) 167.5(c) 169.2(c) 172.8(c) Last
211 014 527 334 294 105 219 685 221 273 Volume
-0.12% -4.84% +1.45% +1.01% +2.13% Change
More quotes
Financials
Sales 2020 871 M 1 042 M 1 042 M
Net income 2020 243 M 291 M 291 M
Net cash position 2020 302 M 361 M 361 M
P/E ratio 2020 39,3x
Yield 2020 0,84%
Sales 2021 1 100 M 1 316 M 1 316 M
Net income 2021 320 M 383 M 383 M
Net cash position 2021 507 M 607 M 607 M
P/E ratio 2021 29,9x
Yield 2021 1,01%
Capitalization 9 436 M 11 282 M 11 289 M
EV / Sales 2020 10,5x
EV / Sales 2021 8,12x
Nbr of Employees 1 908
Free-Float 40,4%
More Financials
Company
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2019, the group had 7 production sites located in Italy, the United States (2), Germany, the United Kingdom, Ireland and South Africa. Net sales are distributed geographically as follows: Europe... 
More about the company
All news about DIASORIN S.P.A.
11/11DIASORIN S P A : North America growth drives up revenues and profitability in th..
PU
11/11DIASORIN S.P.A. : 3rd quarter results
CO
11/11DIASORIN S.P.A. : Press Release
CO
11/09GLOBAL MARKETS LIVE: Berkshire Hathaway, Infineon, McDonald's…
11/04DIASORIN S.P.A. : quaterly earnings release
10/26DIASORIN S P A : launches with CE mark the LIAISON® SARS-CoV-2 Ag, a new high-th..
PU
10/23DIASORIN S P A : Conclusion treasury shares buy-back plan
PU
10/23DIASORIN S P A : Weekly report treasury shares buy-back
PU
10/16DIASORIN S P A : Weekly report treasury shares buy-back
PU
10/01DIASORIN S P A : LIAISON SARS-CoV-2 IgM test receives FDA Emergency Use Authoriz..
PU
10/01DIASORIN S P A : received FDA approval on 6 Hepatitis B tests, completing its He..
PU
09/23DIASORIN S P A : extends its current joint venture with the Chinese Government t..
PU
09/16DIASORIN S P A : Update Annual Calendar of Corporate Events 2020
PU
09/08DIASORIN S P A : and MeMed partner to develop and commercialize novel host immun..
PU
09/07DIASORIN S P A : FDA approval of Simplexa flu A_B & RSV Direct Gen II Assay
PU
More news
News in other languages on DIASORIN S.P.A.
11/09EN DIRECT DES MARCHES : Orange, Airbus, Coface, Infineon, Apple, Codemasters, So..
11/09Le lundi, on est bleu
11/04DIASORIN S.P.A. : publication des résultats trimestriels
11/04DIASORIN S.P.A. : Veröffentlichung des Quartalsergebnisses
10/30Les GAFA ne guérissent pas tous les maux
More news
Stock Trading Strategies
DIASORIN S.P.A. - 11/16
The underlying trend is in force again
BUY
More Stock Trading Analysis
Chart DIASORIN S.P.A.
Duration : Period :
DiaSorin S.p.A. Technical Analysis Chart | DIA | IT0003492391 | MarketScreener
Technical analysis trends DIASORIN S.P.A.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 9
Average target price 160,60 €
Last Close Price 172,80 €
Spread / Highest target 16,6%
Spread / Average Target -7,06%
Spread / Lowest Target -49,7%
EPS Revisions
Managers
NameTitle
Carlo Rosa Chief Executive Officer, Executive Director & GM
Gustavo Denegri Chairman
Piergiorgio Pedron Chief Financial Officer & Senior Corporate VP
Chen Menachem Even Executive Director & Chief Commercial Officer
Franco Moscetti Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DIASORIN S.P.A.49.74%11 282
IDEXX LABORATORIES, INC.70.98%38 746
ALIGN TECHNOLOGY, INC.70.41%37 493
SARTORIUS STEDIM BIOTECH98.78%32 358
SYSMEX CORPORATION40.76%21 519
AMERISOURCEBERGEN CORPORATION21.28%21 079